Incyte plots Delaware expansion as it looks to re-wed commercial, medical teams in its home...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 21, 2024 at 07:02: PM
via As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its U.S. teams back to the nest with a new expansion in the Blue Hen State.

article source
 

<



Similar threads

cafead
ESMO: Even after unique trial win, Incyte CEO views PD-1 drug Zynyz as pipeline aide
Replies
0
Views
14
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Incyte and Syndax&#039;s immunotherapy for transplant complications receives FDA approval
Replies
0
Views
22
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Armed with Phase III win, Incyte eyes label expansion for Monjuvi
Replies
0
Views
16
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Incyte&#039;s treatment for chronic graft-versus-host disease
Replies
0
Views
33
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Incyte drops pair of PD-L1 drugs as part of 2nd pipeline clear-out this year
Replies
0
Views
28
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote